Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI.

In conclusion, our finding may play important role in understanding the mechanisms underlying the problem and should be further evaluated as potential biomarkers in primary resistance of NSCLC. PMID: 29179454 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research